GlassScriptPhysician profile
Desiree Dalcherone
NPI 1053863449
$973.47
in general payments reported to CMS, 2019-2025
10 companies · $58.40 in 2025
The $58.40 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $325 · 2022: $334 · 2023: $221 · 2024: $35.77 · 2025: $58.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $509.77 | 2021-2023 | Puraply |
| Novo Nordisk INC | $155.46 | 2021-2024 | Rybelsus |
| Stryker Corporation | $154.30 | 2021-2022 | |
| Averitas Pharma INC. | $41.86 | 2025 | Qutenza |
| Depuy Synthes Sales INC. | $27.44 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.53 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.00 | 2023 | |
| Merck Sharp & Dohme LLC | $16.54 | 2025 | Capvaxive, Pifeltro |
| Sanofi Pasteur INC. | $14.73 | 2023 | |
| Exact Sciences Corporation | $13.84 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiree Dalcherone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.